David V. Goeddel, Director, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 302,536 shares at $13.45 ($4.1M) on 2022-06-01, disclosed to the SEC on 2022-06-02.
Open-market purchase of $4.1M NGM by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.47 | 2,040 | $27K | 0.7% |
| 2 | $13.47 | 59,766 | $805K | 19.8% |
| 3 | $13.47 | 59,766 | $805K | 19.8% |
| 4 | $13.45 | 3,036 | $41K | 1.0% |
| 5 | $13.45 | 88,964 | $1.2M | 29.4% |
| 6 | $13.45 | 88,964 |
| $1.2M |
| 29.4% |
| Total | $13.46 avg | 302,536 | $4.1M | 100% |
| Filing → |
| NGM | BUY | 2023-11-17 | $18K | — | Filing → |
| TNYA | BUY | 2023-03-14 | $18K | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |